Neurovascular Devices Market market is expected to grow at a CAGR of 7.1% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Neurovascular Devices Market size accounted for USD 4.1 Billion in 2023, growing at a CAGR of 7.1% from 2023 to 2033. Neurovascular devices refer to medical devices designed to treat neurological conditions and disorders related to blood vessels in the brain and spinal cord. These devices are used for the diagnosis, treatment, and management of conditions such as aneurysms,
arteriovenous malformations (AVMs), ischemic strokes, and other vascular issues affecting the nervous system

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021550

The increasing incidence of neurological disorders, such as strokes and aneurysms, has led to a growing demand for neurovascular devices. As the global population ages, the prevalence of these conditions is expected to rise, contributing to market growth. Ongoing advancements in medical technology, such as the development of minimally invasive procedures and innovative neurovascular devices, are driving market growth. These technologies often result in safer and more effective treatments, reducing the overall impact on patients. Increased awareness about neurological conditions, coupled with efforts to promote early diagnosis and treatment, has led to a higher demand for neurovascular devices. Early intervention can significantly improve patient outcomes, driving the adoption of these devices.

Key Players
Some of the major Neurovascular Devices Market players holding high market shares include Medtronic; Johnson and Johnson Services Inc.; Penumbra, Inc.; Micro port Scientific Corporation. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Stryker; Microvention Inc. (Terumo Corporation); Codman Neuro (Integra Lifesciences)

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021550

Segmental Analysis
Based on product, the Neurovascular Devices market is segmented into Embolization Devices, Revascularization Devices, Embolic Protection Devices, and Accessory Devices. Embolization devices are the most widely used type of neurovascular device. These devices are used to block or occlude blood vessels, typically to treat aneurysms or arteriovenous malformations (AVMs). Common embolization devices include embolic coils, liquid embolic agents, and detachable balloons.

Based on disease pathology, the Neurovascular Devices market is Aneurysms, Arteriovenous Malformation (AVM), Ischemic Stroke, Stenosis, and Others. Ischemic stroke is the most common type of stroke. It is caused by a blockage in an artery supplying blood to the brain. Neurovascular devices are used to treat ischemic stroke by removing the blockage and restoring blood flow to the brain. Common devices used to treat ischemic stroke include clot retrievers, stents, and balloon catheters.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.